Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novisia is a pharmaceutical company specializing in aesthetic medicine and dermatology, primarily known as the exclusive distributor of Laboratoires FILLMED products in France and Poland. The company offers a portfolio of high-end medical devices and skincare solutions, including the Art Filler range of hyaluronic acid injectables and the NCTF poly-revitalizing complex. Novisia focuses on providing healthcare professionals, such as dermatologists and plastic surgeons, with advanced tools for non-surgical facial rejuvenation and skin quality improvement. Through its partnership with FILLMED, Novisia supports clinical education and the commercialization of innovative aesthetic treatments. The company is headquartered in Paris and operates as a key commercial vehicle in the European aesthetic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novisia.